Skip to main content
Toggle navigation
Login
Search
Home
2023 Event Program
Icon Legend
This session is not on your agenda.
This session is on your agenda. Click again to remove it.
Presentation Icons
ACVIM Resident Research Award Eligible
Additional Fees May Be Required
By Invite Only
Capturing for On Demand
Cardiology Research Abstract Award Eligible
ERC Approved Lecture for ACVIM Residency
ePoster
Livestream
One Health
Pre-Registration Required
RACE-Approved
Research Abstract
Specialty Symposium
State-of-the-Art (SOTA) Presentation
Veterinary Technician
Oncology
Home
Oncology
Oncology
Type here to filter the list
(O15) Osteopontin Overexpression in Localized Canine Histiocytic Sarcoma
Favorite
(O16) Alternating Rabacfosadine and Doxorubicin for Treatment of Naive Canine Lymphoma
Favorite
(O17) Gene Expression Profiles Associated with Sensitivity to Molecular-Targeted Drugs in Canine Histiocytic Sarcoma Cells
Favorite
(O19) Genome-wide DNA Methylation Analysis Identified Prognostic CPG Site Markers in Canine Multicentric High-grade Lymphoma
Favorite
(O20) Gene Expression Profiles Associated with Early Relapse in Canine Multicentric High-grade B-cell Lymphoma
Favorite
(O21) Genomic Analysis across 50 Canine Cancer Types Reveals Novel Mutations and High Clinical Actionability
Favorite
(O23) The Diagnostic Value of Thymidine Kinase 1 Auto-antibody in Canine Cancer Patients
Favorite
(O24) Novel Genomic Prognostic Biomarkers for Canine Cancer Patients
Favorite
(O25) Assessing the Efficacy of Novel Caninized VEGF Monoclonal Antibody Therapy for Mammary Tumors in Dogs
Favorite
(O26) Anticancer Effect of Superoxide Dismutase on Canine Mammary Gland Tumor in Vitro
Favorite
(O27) Urinary Exosomal Nuclear Matrix protein-22 as a Novel Liquid Biopsy of Urothelial Carcinoma Dogs
Favorite
(O28) Phenotypic Description of T-cell Density in the Tumor Microenvironment of Canine Renal Cell Carcinoma
Favorite
(O29) BTK and BET Inhibition in Canine Lymphoma
Favorite
(O30) A Retrospective Study on Conventional Transarterial Chemoembolization using Idarubicin for Treatment of Canine Hepatic Carcinomas
Favorite
(O31) Usefulness of Computed Tomography in Combination with Iodized Oil (Lipiodol
®
) in Detecting Sentinel Lymph Nodes
Favorite
(O32) Transcriptome Profiling Between Normal and Lymphoma in Comparison of T-cell and B-cell Types in Dogs
Favorite
(O33) The National Cancer Institute's Comparative Osteosarcoma Pathology Board: Toward Harmonized Grading for Humans and Dogs
Favorite
(O34) The National Cancer Institute's Decoding the Osteosarcoma Genome of the Dog (DOG
2
) Project
Favorite
(O35) Macrophage Induced Chemoresistance in Canine Mammary Gland Tumor Cell Spheroid Model
Favorite
(O36) Clinical Outcome of Multicentric Lymphoma Treated with CHOP Protocol in 38 Small-breed Dogs
Favorite
(O38) Evaluation of Mechlorethamine, Vinblastine, Procarbazine, and Prednisone for Treatment of Resistant Multicentric Canine Lymphoma
Favorite